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Abstract 
The gastrointestinal tract harbours a “superorganism” called the gut microbiota, which 
is known to play a crucial role in the onset and development of diverse diseases. This 
internal ecosystem, far from being a static environment, could be willingly 
manipulated by diet and dietary components. Feeding animals with high-fat sucrose 
diets entails diet-induced obesity, a model which is usually used in research to mimic 
the obese phenotype of Western societies.  
 
The aim of the present study was to identify gut microbiota dysbiosis and associated 
metabolic changes produced in 5 male Wistar rats fed a high-fat sucrose (HFS) diet for 
six weeks and to compare it with the basal microbial composition. For this purpose, 
DNA extracted from faeces at baseline and after the treatment was analysed by 
amplification of the V4-V6 region of the 16S ribosomal DNA (rDNA) gene using 454 
pyrosequencing. Short-chain fatty acids (SCFA), acetate, propionate and butyrate, 
were also evaluated by gas chromatography-mass spectrometry (GC-MS).  
 
At the end of the treatment, gut microbiota composition significantly differed at 
phylum level (Firmicutes, Bacteroidetes and Proteobacteria) and class level 
(Erisypelotrichi, Deltaproteobacteria, Bacteroidia and Bacilli). Interestingly, 
Clostridia class showed a significant decrease after the HFS-diet treatment, which 
correlated with visceral adipose tissue, and is likely mediated by dietary 
carbohydrates. Of particular interest, Clostridium cluster XIVa species were 
significantly reduced and changes were identified in the relative abundance of other 
specific bacterial species (Mitsuokella jalaludinii, Eubacterium ventriosum, 
Clostridium sp. FCB90-3, Prevotella nanceiensis, Clostridium fusiformis, Clostridium 
sp. BNL1100 and Eubacterium cylindroides) that, in some cases, showed opposite 
trends to their relative families.  
 
These results highlight the relevance of characterizing gut microbial population 
differences at species level and contribute to understand the plausible link between the 
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diet and specific gut bacterial species that are able to influence the inflammatory 
status, intestinal barrier function and obesity development. 
 




HFS, high-fat sucrose;16S rDNA, 16S ribosomal DNA; SCFA, short-chain fatty acids; 
GC-MS, gas chromatography-mass spectrometry; C, standard-chow diet; PCI, positive 
chemical ionization; PCA, principal component analysis; SD, standard diet; HF, high-
fat diet; WD, western diet. 





Obesity and associated clinical complications are a global health threat (Azagury and 
Lautz, 2011). The prevalence of obesity epidemics has a multifactorial origin that 
results from the interaction between genetics and environmental factors (Martinez et 
al., 2012). Recently, gut microbiota has attracted growing interest as a new 
contributory factor to obesity (Tagliabue and Elli, 2013). The adult intestine is home 
for an approximately 100 trillion microbes, with hundreds or thousands of species, 
occurring in the colonic region, whose density is estimated to be at 1011 to 1012 per ml 
(Million et al., 2013). This gut microbial population has been implicated in a range of 
essential host physiological processes (Evans et al., 2013; Tremaroli and Backhed, 
2012). Moreover, due to the straight interactions between host and microbes, the gut 
microbiota dysbiosis has been associated to a number of diseases such as, diabetes, 
non-alcoholic fatty liver disease and atherosclerosis (Fukuda and Ohno, 2013; Y Lee, 
2013). In this sense, studies directed to investigate the complex association between 
composition and functionality of gut microbes with obesity are emerging (Cani and 
Delzenne, 2011; Ley, 2010). Consumption of high-caloric diets is one of the driving 
forces for obesity development, producing not only an energy imbalance, but also a 
drastic impact on the microbial community residing the gastrointestinal tract (Duca et 
al., 2013; Wu et al., 2011). Despite the fact that the surrounding physiological 
mechanisms are not fully understood, high energy yielding diets rich in fat and sugars 
have been closely related to obesity (Lomba et al., 2010). In this context, further 
investigation of the impact of these types of diets on gut microbiota and their 
metabolic consequences is required (Daniel et al., 2013; Duca et al., 2013), in order to 
identify changes caused in the gut that could be involved in the development of the 
disease. Indeed, the relevance of the intestinal bacteria in metabolism is not only due 
to composition per se, but also to the metabolic activities performed by them. Thus, 
SCFA including acetate, propionate and butyrate, are microbial-derived fermentation 
products that are primarily generated in the large intestine from the metabolism of 
non-digestible polysaccharides, including resistant starch, non-starch polysaccharides 
and oligosaccharides (Flint et al., 2008). Furthermore, these microbial-derived 
products are believed to positively regulate several host metabolic pathways (den 
Besten et al., 2013; Layden et al., 2013). Predominant bacterial groups described as 
major producers of butyrate are Firmicutes, whereas propionate and acetate are mainly 
produced by Bacteroidetes (Macfarlane and Macfarlane, 2003). A number of studies 
have previously reported an increase in faecal SCFA concentrations in obese people 
compared to lean subjects (Ley et al., 2005; Ley et al., 2006; Turnbaugh et al., 2006). 
The changes in the proportion of the different bacterial species have been 
hypothesized to modify the efficiency of energy extraction from the diet (den Besten 
et al., 2013), resulting in a more pro-inflammatory luminal environment that could 
contribute to the progression of low chronic inflammation and metabolic disorders 
(Cani et al., 2013). 
Accordingly, as a consequence of the interplay among diet, gut microbiota and host 
metabolism, this study was focused on characterising microbial community 
modifications and metabolic alterations in rats fed an obesogenic diet based on a high-
fat sucrose intake. GC-MS approach was used to detect SCFA production levels in 
faeces, while gut microbiota profiling was carried out by the high-throughput 16S 






Material and methods 
 
Animals and diets  
The experiment was conducted on five male Wistar rats supplied from Harlan Ibérica 
(Barcelona, Spain), with an average initial body weight of 194±2g and was performed 
in accordance with the Ethical Committee of the University of the Basque Country 
(document reference CUEID CEBA/30/2010), following the European regulations 
(European Convention-Strasburg 1986, Directive 2003/65/EC and Recommendation 
2007/526/EC). Animals were single-housed in polycarbonate cages (Techniplast 
Gazzada, Guguggiate, Italy) and kept in a temperature-controlled (22 ± 2 °C) isolated 
room under a 12:12-h artificial light/dark cycle (light on at 21:00). Rats were fed a 
standard-chow diet (C; 2.9 kcal/g) from Harlan Ibérica (ref. 2014, Barcelona, Spain) 
during an adaptation period of four days and then changed to a high-fat sucrose 
obesogenic diet (HFS; 4.6 kcal/g) purchased from Harlan Ibérica (ref. TD. 06415) for 
6 weeks. The C diet provided 20% of energy as proteins, 67% as carbohydrates and 
13% as fat by dry weight, whereas the HFS diet contained 19% proteins, 36% 
carbohydrates and 45% as fat (Table 1). All animals had free access to food and 
water. Body weight and food intake were measured daily. 
 
Table 1. Composition of the diets: control diet (2014, Harlan Teklad Global 
14% Protein Rodent Maintenance Diet), High-fat sucrose diet (TD. 06415, 
Teklad Research purified diet). 
 Control diet (2014) 
High-fat sucrose diet 
(TD. 06415) 
Energy (Kcal/g) 2.9 4.6 
Protein (Energy %) 20 19 
Carbohydrate (Energy %) 67 36 
             Starch* (g/kg) 480 85 
             Sucrose** (g/kg) Traces 200 
Fat (Energy %) 13 45 
              Saturated (%) 18 36 
              Monounsaturated (%) 20 47 
              Polyunsaturated (%) 62 17 
Fiber content*** (g/kg) 221 58 
 
* Unrefined starch from wheat and corn in 2014; refined corn starch in TD.06415 
** No added sucrose in 2014; trace amounts of simple sugars from grain ingredients 
*** Calculated neutral detergent fiber in 2014 & cellulose in TD.06415  
 
Faeces collection 
Fresh faecal samples were collected at fourth day of the adaptation period and at the 
end of the intervention period, early in the morning, by abdominal massage and prior 
to the overnight fasting. Samples were collected in 15ml Falcon tubes and frozen at     




At the end of the experimental period (6 weeks), animals were fasted overnight and 
sacrificed under anaesthesia (chloral hydrate) by cardiac exsanguination between 9:00 
and 12:00 a.m. White adipose tissue from different anatomical locations (epididymal, 
perirenal, mesenteric and subcutaneous) was collected, weighted and then stored 
frozen at -80 °C.  
Serum biochemical measurements 
Glucose was measured using a Glucose oxidase/peroxidase kit (Ref. 110504, 
BioSystems, Barcelona, Spain), insulin levels were determined by using specific 
ELISA kit according to the protocol described by the manufacturer (Ref. 10-1250-01, 
Mercodia AB, Spain). 
Gut microbiota analysis 
 
DNA extractions  
Total DNA from stool subsamples (180-220 mg) was extracted using a QIAmp DNA 
Stool Mini Kit (Qiagen, Hilden, Germany), following supplier`s instructions. Briefly, 
the method consists on the lysis of the bacterial cells within the faecal material in ASL 
buffer, which is specifically developed to remove inhibitory substances from stool 
samples, adsorption of impurities to InhibitEX reagent and purification of the DNA on 
a spin column. Eluted DNA was quantified using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies) and stored at -20°C until analysis.  
High-throughput amplicon pyrosequencing 
Extracted DNA was used to amplify and to sequence pooled amplicons specific for the   
~ 560bp of the V4-V6 region of the bacterial 16S rDNA gene, which were generated 
using 16S-0515F (5’-TGYCAGCMGCCGCGGTA-3’) and 16S-1061R                    
(5’-TCACGRCACGAGCTGACG-3’) primers tailed on each end with the Roche 
multiplex identifiers. This barcode-based primer approach allowed sequencing of 
multiple samples in a single sequencing run without the need for physical partitioning. 
Specific PCR conditions for the pfu DNA polymerase (Ref. M774, Promega, Madison, 
WI) were performed in order to get the amplicons following manufacturer´s 
instructions. PCR products were then cleaned using the PCR purification Kit (Qiagen) 
and DNA concentrations were determined using the Quant-iT PicoGreen dsDNA 
reagent and kit (Invitrogen, California, USA) as previously described (Milagro et al., 
2011). The final pool of cleaned amplicons combined in equimolar ratios into a single 
tube was prepared taking 100 ng from each sample in a total volume of 55.61 μl. 
Single- ended pyrosequencing was carried out by Beckman Coulter Genomics 
(Danvers, MA, USA) on a 454 Life Sciences Genome Sequencer FLX instrument 
(Roche), following one pippin prep, for size selection of the amplicons of interest. The 
sequence of the 10 amplicon libraries produced 16S rDNA reads ranging from 11, 808 
to 34, 934, generating read lengths with an average of 517 bp. The reads were 
clustered using the open source MIRA (Chevreux et al., 2004) assembler in EST mode 
with an identity threshold of 0.98, minimum coverage of 1x and minimal contig length 
of 400bp, contigs and singletons were blasted against a curated copy of the RDP 
database and blast results were provided to MEGAN (Huson et al., 2011) for 
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taxonomic classification. Construction of libraries and sequencing were all provided as 
a custom service of Beckman Coulter Genomics.  
 
Short chain fatty acids analysis  
Reagents and standards 
Diethyl ether CHROMASOLV for HPLC was from Sigma-Aldrich (Steinheim, 
Germany), while water was produced in a Milli-Q purification system (Millipore, 
Molsheim, France). Phosphoric acid was purchased from Sigma-Aldrich. Analytical 
standards sodium acetate, sodium propionate, sodium butyrate and propionic acid-d6 
(98 atom %D) was from Sigma-Aldrich. 
Calibration 
Individual standard stock solutions of the SCFA of 2000 mg/L were prepared in water 
and stored at -20ºC until use. Immediately before assay, dilutions in acid water (0.5% 
phosphoric acid) were performed to generate a calibration series at concentration 
range of 0.1 to 500 mg/L of the three standards. Internal standard (propionic acid-d6, 
98 atom %D) was prepared at a concentration of 2 mg/L in acid water. A volume of 
500µL of this solution was added to calibrators before extraction.  
Sample preparations 
Exactly 500 μL of acid water (containing internal standard) was added to 25 mg of 
each baseline and final lyophilized sample. Overnight lyophilization was carried out 
protecting samples from light. Mixture was shaken for 1 minute. Afterwards, 
extraction was carried out with 500 μL of diethyl ether followed by 1 minute of 
shaking and centrifugation at 4ºC at 14000 rpm for 10 min. Supernatants were 
analysed. 
Gas chromatography-mass spectrometry analysis 
Samples were analysed in a 7890A Series gas chromatograph coupled to a 7000 
GC/MS Triple Quad (Agilent Technologies, Santa Clara, U.S.A.). Chromatographic 
column was a J&W Scientific HP-FFAP (30 m x 0.25 mm i.d., 0.25 µm film) (Agilent 
Technologies). A volume of 1µl of sample was automatically injected into a 
split/splitless inlet (in splitless mode), which was kept at 175ºC. Helium (99.999% 
purity) was used as a carrier gas, at a flow rate of 1 ml/min in constant flow mode. The 
oven program was set at an initial temperature of 90°C, increased to 150°C at a rate of 
12°C/min, then increased to 240ºC at a rate of 20ºC/min, and held at 240°C for 5 min. 
Ionization was done by positive chemical ionization (PCI) with methane gas. SIM 
mode was used for the acquisition. GC-QqQ MassHunter acquisition software 
(Agilent Technologies) was used for data acquisition.  
Statistical analysis 
All results are expressed as the mean± standard error of the mean. Statistical 





At class level, significant differences in major bacterial groups were detected when 
comparing gut microbiota composition at the beginning and at the end of the 
intervention. A “bloom” in Erysipelotrichi, one of the major classes within the 
Firmicutes phylum, was observed and a significant increase of Deltaproteobacteria, a 
class of Proteobacteria was identified. Although no statistically significant outcomes 
after adjusting by multiple comparison test were found, an enhancement of 
Gammaproteobacteria (433%) was also identified (Table 2). Surprisingly, the levels 
of Clostridia (-30%) and Bacilli (-79%) classes, belonging both to the phylum 
Firmicutes, were decreased. Unexpectedly, a positive correlation was detected 
between Clostridia levels and animals´ visceral adipose tissue percentage (p= 0.037; 
r= 0.900) (Figure 3). On the other hand, a significant fall in the relative abundance of 
Bacteroidia (-69%), a member of Bacteroidetes phyla, was found after the 
intervention period (Table 2).  
There were no differences in total bacterial 16S rDNA frequencies of the samples 
between baseline and the end of the treatment. However, statistically significant 
increases were found for Firmicutes (35%) and Proteobacteria (509%) phyla at the 
end of the experimental period. Accordingly, Bacteroidetes were reduced on average 
by 69%. Relative abundance of other phyla found in lower levels, such as 
Actinobacteria (from 0.7% to 0.4%), Clamydiae/Verrucomicrobia group (from 0.2% 
to 1%), Tenericutes (from 0.4% to 2.7%), Cyanobacteria (from 0.3% to 0.4%), 
Deferribacteres (0.5%) and unclassified bacteria (from 0.4% to 0.3%), were also 
statistically different between baseline and the end of the HFS diet intervention, but 
changes were non-significant. Faecal bacterial populations identified before and after 
the HFS-diet treatment at phylum level are illustrated in Figure 2a and 2b.  
After six weeks of HFS diet, rats gained an average weight of 176±7 g. At the end of 
the intervention, animals presented significantly higher final body weight (p< 0.05) 
when compared to baseline (Figure 1). A total of 209, 709 reads (84, 604 at baseline 
and 125, 105 at the end of the treatment) were obtained when V4-V6 regions of 16S 
rDNA gene were sequenced to assess the impact of the HFS diet on bacterial 
community. Across all samples measured at the beginning and at the end of the 
experiment, the average length of quality sequences ranged from 499 to 532 bp. In 
faeces of the experimental rats, members from Firmicutes phyla were predominant, 
representing from 61-96% of 16S rDNA gene sequences, followed by Bacteroidetes, 
the second most abundant phyla (2-37%). These two divisions were more than 90% of 
the sequences before and after the treatment period.  
Effect of a high-fat sucrose diet on weight and bacterial community structure  
Results 
Hochberg multiple testing corrections was applied for variables presenting 
probabilities of p< 0.05, unadjusted p values which were lower than the calculated 
critical values were considered statistically significant. SPSS 15.0 software (Chicago, 
USA) was used to perform statistical analysis and principal component analysis (PCA) 
was performed using XLSTAT software (http://www.xlstat.com). 
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Ribosomal Database Project classification Bacterial group HFS baseline HFS after treatment Change (%)  Unadjusted  p value 
Critical 
 p value 
Firmicutes; Clostridia Clostridia 0.572±0.015 0.396±0.021 -30.7  0.001 * 
Bacteroidetes; Bacteroidetes; Bacteroidia Bacteroidia 0.350±0.011 0.107±0.037 -69.4  0.001 * 
Firmicutes; Erysipelotrichi Erysipelotrichi 0.038±0.024 0.425±0.064 1025.4  0.002 * 
Firmicutes; Bacilli Bacilli 0.015±0.002 0.003±0.001 -79.8  0.002 * 
Proteobacteria; delta/epsilon subdivisions; Deltaproteobacteria Deltaproteobacteria 0.002±0.001 0.026±0.005 1575.7  0.011 * 
Proteobacteria; Gammaproteobacteria Gammaproteobacteria 0.001±0.000 0.004±0.001 433.0  0.020 ns 
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Taxonomic breakdown of Wistar rats intestinal bacterial V4-V6 regions obtained by pyrosequencing before and after HFS diet treatment. All results are expressed as the taxa frequencies 
mean± SEM and the average of bacterial relative abundance change (%) between final and baseline. Statistical analyses were performed using Paired- Samples T-test. Variables presenting 
probabilities of p 0.05 were applied the Benjamini-Hochberg multiple testing correction. Unadjusted p values lower than the calculated critical p values were considered statistically 
















At family level, the relative proportion of most of the detected bacterial groups 
(Lachnospiraceae, Eubacteriaceae, Lactobacillaceae, Porphyromonadaceae, 
Rikenellaceae and Clostridiales Family XIII incertae sedis) was lower at the end of 
the HFS diet intervention when compared to the baseline, although these results 
remained not statistically significant after applying the correction with the multiple 
comparison test (Table 3).  However, a significant reduction in the Prevotellaceae      
(-96%) family, within the Bacteroidetes division (p< 0.001), was detected. 
Furthermore, the Prevotellaceae/Bacteroidaceae ratio was significantly lower          
(p< 0.001) in the diet-induced overweight rats (Figure 4). In contrast, 
Desulfovibrionaceae (966%), unclassified Erysipelotrichiciae (6055%), 
Peptococcaceae (130%) and Xanthomonadaceae (227%) increased considerably 
(although not statistically significantly) after the treatment period (Table 3). 
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  p value 
Critical 
value 
Bacteroidetes/Chlorobi group; Bacteroidetes; Bacteroidia; 
Bacteroidales; Prevotellaceae 
Prevotellaceae 0.171±0.018 0.006±0.001 -96.5 0.001 * 
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae Lachnospiraceae 0.089±0.014 0.037±0.006 -58.9 0.042 ns 
Firmicutes; Clostridia; Clostridiales; Eubacteriaceae Eubacteriaceae 0.024±0.002 0.018±0.001 -24.1 0.050 ns 
Firmicutes; Clostridia; Clostridiales; Peptococcaceae Peptococcaceae 0.004±0.000 0.008±0.001 130.1 0.013 ns 
Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae Lactobacillaceae 0.012±0.002 0.002±0.001 -80.7 0.005 ns 
Proteobacteria; Gammaproteobacteria; Xanthomonadales; 
Xanthomonadaceae 
Xanthomonadaceae 0.002±0.001 0.005±0.000 227.6 0.016 ns 
Firmicutes; Erysipelotrichi; Erysipelotrichales; 
Erysipelotrichaceae; unclassified Erysipelotrichaceae 
Unclassified 
Erysipelotrichaceae 
0.005±0.003 0.326±0.063 6055.4 0.006 ns 
Proteobacteria; delta/epsilon subdivisions; 
Deltaproteobacteria; Desulfovibrionales; 
Desulfovibrionaceae 
Desulfovibrionaceae 0.002±0.001 0.026±0.005 966.8 0.011 ns 
Bacteroidetes/Chlorobi group; Bacteroidetes; Bacteroidia; 
Bacteroidales; Porphyromonadaceae 
Porphyromonadaceae 0.144±0.022 0.017±0.009 -88.4 0.003 ns 
Bacteroidetes/Chlorobi group; Bacteroidetes; Bacteroidia; 
Bacteroidales; Rikenellaceae 
Rikenellaceae 0.004±0.001 0.003±0.001 -41.0 0.009 ns 
Firmicutes; Clostridia; Clostridiales; Clostridiales incertae 
sedis; Clostridiales Family XIII. incertae sedis 
Clostridiales Family XIII. 
incertae sedis 
0.005±0.000 0.001±0.001 -72.1 0.016 ns 
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Taxonomic breakdown of Wistar rats intestinal bacterial V4-V6 regions obtained by pyrosequencing before and after HFS diet treatment. All results are expressed as the taxa 
frequencies mean± SEM and the average of bacterial relative abundance change (%) between final and baseline. Statistical analyses were performed using Paired- Samples T-test. 
Variables presenting probabilities of p 0.05 were applied the Benjamini-Hochberg multiple testing correction. Unadjusted p values lower than the calculated critical p values were 
considered statistically significant (*). HFS, high-fat sucrose; SEM, standard error of the mean. 
Table 3. Taxa frequencies and percentage of change (%) of the relative abundance of bacterial groups at family level in rats at baseline and after a 6 week HFS diet 
treatment.  
A clustering of microbiota analysis by Principal Component Analysis (PCA) revealed 
that distribution of animals at baseline and after the treatment was characterized by 
differentiated bacterial families (Figure 5a and 5b). Twenty six bacterial families 
represented faecal gut microbiota in control diet-fed lean rats, while twenty one groups 
of bacteria characterized gut microbial community in faces samples after the six week 
HFS diet intervention. 
Association of diet-induced overweight to signature of genera and species 
High-throughtput pyrosequencing enabled not only to detect a distinct microbial 
population pattern at higher division levels, but also made possible to identify 
significant alterations in the relative abundance of several bacterial genera and specific 
bacterial species in faeces of control diet-fed rats that were submitted to a high-fat 
sucrose diet treatment. Thus, Mitsuokella genus showed a statistically significant 
reduction concerning percentage of change (-90%), and Maribacter (a genus within the 
Flavobacteriaceae family) presented a significant increase in its relative abundance 
(455%) at the end of the treatment. In agreement with the aforementioned results, at 
species levels, relative abundance of Mitsuokella jalaludinii, was significantly lower in 
the HFS diet-induced overweight rats. Some bacterial species showed the opposite 
pattern to the families or genus they belong to. Thus, Eubacterium ventriosum, a 
bacterial species from the Eubacteriaceae family, was significantly increased (384%), 
while the Eubacteriaceae family decreased (-24%) in the HFS diet-fed rats. Similarly, 
Prevotella nanceiensis, from the Prevotellaceae family, was significantly enriched 
(322%), and other Prevotella species also showed a considerable enhancement 
(Prevotella micans, 157%; Prevotella marshii, 205%) after 6 weeks of a HFS diet 
treatment. Moreover, although Clostridia class presented a reduction at the end of the 
experimental period, some species from this group were detected to be significantly 
enriched in overweight rats, such as Clostridum sp. FCB90-3 (414%) and Clostridium 
sp. BNL1100 (219%). In contrast, other Clostridium species showed significantly lower 
levels in the faeces of the diet-induced obese rats, such as Clostridium fusiformis          
(-77%). Although the percentage of change was not statistically significant, when the 
relative abundance of bacteria was compared at baseline and after the HFS diet 
treatment, some bacterial species such as Eubacterium cylindroides (4072%), Bilophila 
wadsworthia (406%) and Clostridium algidixylanolyticum (235%) substantially 
increased in the faeces of the diet-induced overweight rats, while other species showed a 
considerable decrease (Clostridium hathewayi, -85%; Clostridium aerotolerans,             
-68.9%; Clostridium clariflavum, -89%; Clostridium aminobutyricum, -74%. Some 
members of the phylum Bacteroidetes were also found to extensively increase in the 
diet-induced obese rats (Bacteroides heparinolyticus, 204%; Bacteroides sp. S-18, 
1526%; Bacteroides sp. dnLKV7, 427.8%). The relative abundance of these microbes 
whose percentage changed in the faeces from the HFS diet-fed rats before and after the 






Table 4. Taxa frequencies and percentage of change (%) of the relative abundance of bacterial groups at species level in rats at baseline and after a 6 week HFS diet treatment.  





Firmicutes Veillonellaceae Mitsuokella Mitsuokella jalaludinii 0.005±0.000 0.000±0.000 -91.4 0.001 * 
Firmicutes Eubacteriaceae Eubacterium Eubacterium ventriosum 0.001±0.000 0.005±0.000 384.2 0.001 * 
Firmicutes Clostridiaceae Clostridium Clostridium sp. FCB90-3 0.004±0.001 0.005±0.000 414.5 0.001 * 
Bacteroidetes Prevotellaceae Prevotella Prevotella nanceiensis 0.001±0.000 0.005±0.000 322.3 0.001 * 
Firmicutes Clostridiaceae Clostridia Clostridium fusiformis 0.005±0.000 0.001±0.000 -77.1 0.001 * 
Firmicutes Clostridiaceae Clostridium Clostridium sp. BNL1100 0.002±0.000 0.005±0.000 219.8 0.001 * 
Firmicutes Erysipelotrichaceae Clostridium Eubacterium cylindroides 0.005±0.003 0.191±0.041 4072.1 0.009 ns 
Firmicutes Clostridiaceae Clostridium Clostridium hathewayi 0.037±0.008 0.005±0.001 -85.6 0.018 ns 
Firmicutes Clostridiaceae Clostridium Clostridium sp. C9 0.002±0.001 0.004±0.001 130.7 0.050 ns 
Firmicutes Clostridiaceae Clostridium Clostridium xylanovorans 0.005±0.002 0.002±0.001 -61.1 0.041 ns 
Firmicutes Clostridiaceae Clostridium Clostridium aerotolerans 0.005±0.000 0.002±0.001 -68.9 0.016 ns 
Firmicutes Clostridiaceae Clostridium Clostridium clariflavum 0.004±0.001 0.000±0.000 -89.5 0.017 ns 
Firmicutes Clostridiaceae Clostridium Clostridium aminobutyricum 0.005±0.000 0.001±0.001 -74.6 0.016 ns 
Firmicutes Clostridiaceae Clostridium Clostridium algidixylanolyticum 0.001±0.001 0.005±0.000 235.4 0.017 ns 
Firmicutes Clostridiales Family XIII. 
Incertae Sedis 
 [Eubacterium] infirmum 0.005±0.000 0.001±0.001 -72.8 0.016 ns 
Firmicutes Eubacteriaceae Eubacterium Eubacterium plexicaudatum 0.008±0.001 0.002±0.001 -69.7 0.001 ns 
Firmicutes Eubacteriaceae Eubacterium Eubacterium fissicatena 0.005±0.000 0.002±0.001 -69.0 0.016 ns 
Firmicutes Eubacteriaceae Eubacterium Eubacterium siraeum V10Sc8a 0.002±0.001 0.005±0.000 195.2 0.018 ns 
Firmicutes Ruminococcaceae Ruminococcus Ruminococcus flavefaciens 0.009±0.001 0.004±0.001 -59.1 0.006 ns 
Firmicutes Ruminococcaceae Ruminococcus Ruminococcus sp. NML 00 0124 0.003±0.001 0.005±0.000 82.1 0.029 ns 
Firmicutes Ruminococcaceae Ruminococcus Ruminococcus faecis 0.005±0.000 0.002±0.001 -69.0 0.017 ns 
Firmicutes Lachnospiraceae Blautia [Ruminococcus] obeum 0.008±0.002 0.002±0.000 -76.8 0.043 ns 
Firmicutes Lachnospiraceae Blautia Blautia sp. Ser5 0.006±0.001 0.002±0.001 -64.6 0.033 ns 
Firmicutes Lachnospiraceae Blautia Ruminococcus gnavus 0.004±0.001 0.001±0.001 -61.0 0.028 ns 
Firmicutes Lachnospiraceae Blautia [Ruminococcus] torques 0.001±0.000 0.001±0.000 74.9 0.044 ns 
Firmicutes Lachnospiraceae Marvinbryantia Marvinbryantia formatexigens 0.008±0.003 0.001±0.000 -91.7 0.049 ns 
Firmicutes Lactobacillaceae Lactobacillus Lactobacillus reuteri 0.001±0.001 0.005±0.000 236.8 0.016 ns 
Proteobacteria Desulfovibrionaceae Bilophila Bilophila wadsworthia 0.005±0.000 0.025±0.005 406.7 0.012 ns 
Proteobacteria Xanthomonadaceae Frateuria Frateuria aurantia 0.002±0.001 0.005±0.000 229.4 0.016 ns 
Actinobacteria Coriobacterineae Asaccharobacter Asaccharobacter celatus 0.005±0.000 0.002±0.001 -67.2 0.016 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella brevis 0.039±0.009 0.005±0.000 -87.1 0.018 ns 
Bacteroidetes Prevotellaceae Paraprevotella Paraprevotella xylaniphila 0.009±0.001 0.002±0.001 -78.1 0.005 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella micans 0.002±0.001 0.005±0.000 157.6 0.004 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella marshii 0.002±0.001 0.005±0.000 205.3 0.004 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella copri 0.002±0.001 0.005±0.000 133.1 0.037 ns 
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Table 4. Continued 





Bacteroidetes Prevotellaceae Prevotella Prevotella sp. DJF B116 0.008±0.001 0.005±0.000 -38.9 0.040 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella sp. oral taxon 302 0.002±0.001 0.005±0.000 114.8 0.025 ns 
Bacteroidetes Prevotellaceae Prevotella Prevotella sp. B31FD 0.001±0.001 0.005±0.000 247.0 0.016 ns 
Bacteroidetes Bacteroidaceae Bacteroides Bacteroides heparinolyticus 0.002±0.001 0.005±0.000 204.2 0.016 ns 
Bacteroidetes Bacteroidaceae Bacteroides Bacteroides sp. S- 18 0.002±0.001 0.040±0.012 1526.4 0.035 ns 
Bacteroidetes Bacteroidaceae Bacteroides Bacteroides sp. dnLKV7 0.003±0.001 0.013±0.004 427.8 0.043 ns 
Bacteroidetes Bacteroidaceae Bacteroides Bacteroides sp. Human4 0.005±0.000 0.001±0.001 -71.0 0.017 ns 
Bacteroidetes Bacteroidaceae Bacteroides Bacteroides dorei 0.005±0.000 0.003±0.001 -48.5 0.044 ns 
Bacteroidetes Porphyromonadaceae Barnesiella Barnesiella intestinihominis 0.082±0.012 0.006±0.003 -93.0 0.002 ns 
Bacteroidetes Porphyromonadaceae Barnesiella Barnesiella viscericola 0.019±0.004 0.003±0.001 -84.9 0.015 ns 
Bacteroidetes Porphyromonadaceae Porphyromonas Porphyromonas endodontalis 0.001±0.000 0.004±0.001 244.5 0.043 ns 
Bacteroidetes Porphyromonadaceae Barnesiella Barnesiella sp. NSB1 0.029±0.006 0.005±0.003 -83.3 0.006 ns 
Bacteroidetes Flavobacteriaceae Maribacter Maribacter sp. ZS1-8 0.002±0.001 0.005±0.000 189.0 0.017 ns 
Tenericutes Acholeplasmataceae Phytoplasma 16SrIII (X-disease group) 0.001±0.001 0.005±0.000 265.7 0.016 ns 
Tenericutes Acholeplasmataceae Phytoplasma 'Spartium junceum' witches'-broom 
phytoplasma 
0.002±0.001 0.005±0.000 0.018 ns 206.9 
 
Taxonomic breakdown of Wistar rats intestinal bacterial V4-V6 regions obtained by pyrosequencing before and after HFS diet treatment. All results are expressed as the taxa frequencies    
mean± SEM and the average of bacterial relative abundance change (%) between final and baseline. Statistical analyses were performed using Paired- Samples T-test. Variables presenting 
probabilities of p 0.05 were applied for the Benjamini-Hochberg multiple testing corrections. Unadjusted p values lower than the calculated p critical values were considered statistically    





SCFA profiles  
Follow-up GC-MS analysis of faecal contents showed significantly lower (p< 0.05) 
concentrations of acetate (1.68 ± 0.39 mg/g) and propionate (0.41 ± 0.11 mg/g) at the 
end of the study compared to the baseline (6.40 ± 0.54; 1.27 ± 0.10 mg/g, respectively) 
while final butyrate levels (0.38 ± 0.11 mg/g) present a trend (p= 0.083) to be reduced 
in comparison to the contents measured in faeces at the beginning of the study (9.46 ± 
3.95 mg/g). Moreover, faecal matter collected in 24h was significantly (p= 0.042) 
reduced at the end of the treatment (1.8 ± 0.6 g) compared to baseline (7.0 ± 0.5 g). 
Thus, absolute amounts of acetate (44.81 ± 3.80 mg) and propionate (8.89 ± 0.71 mg) 
before treatment were significantly higher (p< 0.001) and decreased after the HFS diet 
(acetate, 3.02 ± 0.70 mg; propionate, 0.74 ± 0.20 mg), whereas initial total butyrate 
quantities (66.21 ± 27.64 mg) showed a trend (p= 0.077) to be reduced (0.69 ± 0.19 mg) 
after the HFS diet treatment (Figure 6a and 6b). 
Discussion 
Gut microbiota composition is usually altered in metabolic diseases (Fukuda and Ohno, 
2013). Also, dietary patterns rich in fat and carbohydrates have been reported to modify 
the bacterial community at high phylogenetic levels (de La Serre et al., 2010; Parks et 
al., 2013). Furthermore, the bacterial structure modifications as a result of small 
variations in dietary macronutrients have been characterized (Patrone et al., 2012). In 
this context, our study aimed to demonstrate the gut microbiota susceptibility to 
modifications in diet-induced overweight rats at different phylogenetic levels. 
Moreover, the current research sought to further demonstrate how a Westernized diet 
might importantly affect the gut microbiota composition, by the implementation of an 
experimental model fed a diet rich in fat and sucrose that resembles and simulates the 
overweight and obesity associated metabolic alterations in humans. On the other hand, 
these results provide information about the role of the diet in gut microbial population 
of a unique group of animals that has been analysed at two different time points 
(baseline and at the end of the HFS diet treatment), thereby avoiding inter-individual 
differences. 
 
16S rRNA sequence-based analytical methods have unveiled that Gram positive 
Firmicutes and Gram negative Bacteroidetes constitute over 90% of the known 
phylogenetic categories and are the dominant divisions in the distal gastrointestinal tract 
from human volunteers (Qin et al., 2010). This trial confirms that the consumption of a 
HFS diet during 6 weeks causes a restructuring of gut microbial community in rats, 
supporting data from other authors (Parks et al., 2013) that assure the differential 
characterization of gut microbiota between standard diet-fed lean rats and HFS diet-
induced obese rats. In this sense, our study demonstrates that the HFS diet treatment 
causes a significant increase of bacteria belonging to the phylum Firmicutes and 
Proteobacteria, accompanied with a division-wide suppression of Bacteroidetes. These 
data agree with the obesity-associated compositional pattern reported by Gordon and 
colleagues (Ley et al., 2005) for obese humans and obese (ob/ob) mice, finding the 
increase in the ratio Firmicutes to Bacteroidetes to be higher at the end of the HFS 
intervention. The overweight state has been previously characterized by reduced 
proportions of the phylum Bacteroidetes and equivalent enrichments in Firmicutes 
(increased Firmicutes-to-Bacteroidetes ratio) (Ley et al., 2005 Ley et al., 2006; ; 
Murphy et al., 2010). However, this assumption is under debate as some groups were 
not able to detect differences between obese and non-obese subjects for the phylum 
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Bacteroidetes (Duncan et al., 2008), other researchers demonstrated the opposite results 
by reporting that obese subjects harboured more bacteria from this phylum than normal-
weight individuals (Zhang et al., 2009) and other investigators have even found lower 
Firmicutes to Bacteroidetes ratio (Schwiertz et al., 2010). On the other hand, in this 
study a significant enrichment in Proteobacteria was also found, which is consistent 
with the results published by Hildebrandt et al. (Hildebrandt et al., 2009). This group 
elegantly demonstrated that the effect of the diet dominated over the obese state on gut 
microbiome composition. The authors took advantage of the use of RELMβ KO mice, 
which remained lean when fed a high-fat diet, and compared the results obtained with 
high-fat diet fed wild type mice. Our findings are similar to those reported by this 
group, as the authors demonstrated an increase in the abundance of the Proteobacteria 
phylum. 
Not only the whole Firmicutes phylum, but a predominant class (the Mollicutes) within 
this group has been associated to western-diet related gut microbiota (Turnbaugh et al., 
2008). Our data agree with previous metagenomic analyses performed in diet-induced 
obese mice showing a bloom in the Erysipelotrichi class within the Firmicutes phylum 
(Fleissner et al., 2010 Turnbaugh et al., 2008 Turnbaugh et al., 2009; ; ). In this context, 
it has been hypothesized that this group of bacteria could has the capacity to take up 
oligo- and monosaccharides from Western diets, such as glucose, fructose and sucrose, 
in order to produce ready to absorb short-chain fatty acids by their metabolism 
(Conterno et al., 2011). Moreover, these data should also consider the relevance of the 
increased body weight and possible metabolic changes related to the acquired 
overweight as a possible explanation for the increased Erysipelotrichi abundance. In 
this sense, abundance of the taxa Erysipelotrichiciae, together with the levels of 
Coriobacteriaceae and Gammaproteobacteria, has also been associated to alterations in 
lipid metabolism in the context of obesity, metabolic syndrome, and 
hypercholesterolemia (Martinez et al., 2013 Spencer et al., 2011; ). However, it could 
not be concluded that the enrichment in Erysipelotrichiciae detected in our study, is 
related to the host lipid and cholesterol phenotypes as we do not have biochemical data 
from these variables at the beginning of the study. Anyway, our group has previously 
reported a marked increase in body weight, subcutaneous and visceral fat depots due to 
the HFS diet in this experimental model that is accompanied by singular metabolic 
impairments (Boque et al., 2013). Therefore, it is likely that the metabolic derangement 
caused by the increased intake of fat and sugars given by the HFS diet could have 
produced a direct effect on this specific taxa. Indeed, the fact that the gut microbiota 
composition could be independent of the host phenotype, with the diet being the major 
contributory factor for its altered composition, has been previously reported in weight- 
reduced mice (Ravussin et al., 2012), and also in lean/ obese mice phenotypes 
(Hildebrandt et al., 2009). In this sense, an enhancement in Delta-Proteobacteria class 
and the order Desulfovibrio as a consequence of the high-fat diet was demonstrated by 
Hildebrandt et al. (Hildebrandt et al., 2009). In agreement with these findings, an 
enlargement in the Desulforvibrionaceae family after the HFS diet treatment was also 
detected in our study after the HFS diet treatment. It should be highlighted that the 
family Desulfovibrionaceae, in spite of not being so well known, has been described as 
a sulphate-reducing, endotoxin-producing bacteria and has been positively associated 
with obesity and/or type 2 diabetes (Hildebrandt et al., 2009 Zhang et al., 2010; ). 
Furthermore, significant reductions observed in the Bacteroidia class and the 
Prevotellaceae family in our study, are in accordance with the HFS diet-induced 
decreases found by Hildebrandt et al. (Hildebrandt et al., 2009) in the families of 
Bacteroidaceae, Prevotellaceae and Rikenellaceae. Moreover, our data evidenced a 
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lower Prevotellaceae/Bacteroidaceae ratio at the end of the intervention period. 
Interestingly, this ratio has been previously reported to be increased after a weight loss 
intervention (Nadal et al., 2009; Santacruz et al., 2009).  
Nevertheless, there is a key bacterial group that has been found to differ in our study 
when compared to other studies (de La Serre et al., 2010 Hildebrandt et al., 2009; ). Our 
results showed a significant decrease in Clostridia after the HFS diet treatment, while 
Hildebrandt et al. (Hildebrandt et al., 2009) and other authors (de La Serre et al., 2010) 
have reported an enhancement of this bacterial group in high-fat diet-fed mice and rats. 
We speculate that the disparity found regarding Clostridia class, might originate from 
differences in the carbohydrate contents of the diets. As mentioned in material and 
methods sections, our rats were fed a standard diet at the beginning of the intervention 
(low in fat and simple sugars, high in fiber) and then switched to a high-fat, high-
sucrose diet. This variation in the type and content of carbohydrates could cause 
changes in specific bacterial groups, such as the Clostridia class, which differs from the 
alterations produced by a purified high-fat diet. In fact, it has been demonstrated that 
Clostridium, which is an obligate anaerobe genus, is susceptible to changes associated 
to the digestible carbohydrate content of the diet, (i.e. corn starch), their counts being 
increased with high starch diets (Cresci et al., 1999). This finding may assume a 
possible direct impact of the type and quantity of carbohydrates on gut microbiota 
composition. Supporting this hypothesis, Fleissner et al. (Fleissner et al., 2010) studied 
the influence of a standard (SD), a high-fat (HF) and a commercial Western diet (WD) 
on faecal microbiota composition of conventional mice. Our data are consistent with the 
reductions of bacterial families reported by them in the HF and WD-fed animals, 
including Bacillaceae, Lachnospiraceae, Lactobacillaceae, Porphyromonadaceae, 
Rikenellaceae, Prevotellaceae and Bacteroidaceae. Interestingly, the gut microbiota of 
HF and WD-fed mice was enriched in the Erysipelotrichiciae family as previously 
mentioned, but the Clostridiaceae family suffered a decrease when the mice were fed 
the WD. 
The consequences of the fermentation of different types of carbohydrates have been 
extensively analysed elsewhere (den Besten et al., 2013 Louis et al., 2007; ).            
Non-digestible carbohydrates reach intact the cecum and are key constituents to modify 
gut microbiota composition and hence, the type and amount of SCFA produced 
(Campbell et al., 1997). This study revealed a significant reduction in the total amount 
of acetate and propionate, but only a tendency to decrease was found for butyrate. The 
latter might be due to the high- variability given within animals in the levels of this 
metabolite at baseline. Moreover, it should also be taken into consideration that as a 
consequence of the lower total amount of faecal matter collected at the end of the study 
compared to baseline a considerable reduction in the absolute amounts of SCFA was 
found. Indeed, these differences in faecal matter might be partly attributed to the 
constipation that the HFS diet could produce in animals resulting from a lower fiber and 
resistant starch content. Nonetheless, these results contradict data from previously 
reported experiments (Ley et al., 2005 Ley et al., 2006 Turnbaugh et al., 2006; ; ). 
Briefly, Turnbaugh et al. (Turnbaugh et al., 2006) characterized the distal gut 
microbiota differences in ob/ob mice and their lean littermates (ob/+, +/+) removing 
confounding factors such as, environmental, dietary and genotype factors. The authors 
hypothesized that the C57BL/6J ob/ob genotype had a greater capacity to energy harvest 
from the diet. To test this hypothesis, caecal microbiota from C57BL/6J lean and obese 
donors was transplanted to germ-free C5BL/6J recipients. Such findings confirmed that 
the donor microbiota was transmissible. In addition, it was demonstrated that those 
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animals who received the obese microbiota, showed a significantly higher percentage 
increase in body fat and a greater production of SCFA in the caeca of conventionally 
raised C57BL/6J mice. Altogether, this study concluded that the obese phenotype is 
transmissible and present an enlarged capacity to extract energy from the diet. 
Concerning our outcomes, the possible main reason for the observed differences in the 
detected SCFA, might be behind the experimental model used. The above mentioned 
studies were performed in genetically obese phenotypes, homozygous for a mutation in 
the leptin gene (Lepob), which produces obesity regardless of food intake, whereas our 
model, depends on the amount and type of fat and carbohydrates consumed to develop 
the disease, which in turn, may affect microbial composition and their primary 
fermentation products. Nevertheless, it is important to remark that these measurements 
in faeces are useful when talking about changes in excretion, but are imprecise if 
production of these molecules are to be discussed, since their content in faeces depends 
on the absorption by the host and is influenced by rates of transit (Topping and Clifton, 
2001).  
Approaches based on 16S rRNA (16S rDNA) analyses have enabled to detect 
taxonomic differences in microbial communities at phylum level, but also have 
demonstrated to be valuable tools to identify genus- and species-specific alterations 
(Lamendella et al., 2012). Moreover, clustering of bacterial families based on PCA, 
showed a clear representation of differentiated lineages of bacteria between samples 
collected before the intervention period when rats were fed a control-diet during the 
adaptation period, and HFS diet-fed overweight rats. On the other hand, the evaluation 
of gut microbiota composition in faecal samples from lean and diet-induced overweight 
rats, demonstrated that there are specific bacterial species that present considerable 
percentages of change at the end of the treatment when compared to the baseline. One 
of these species is Mitsuokella jalaludinii, significantly depleted after the HFS 
treatment. Mitsuokella jalaludinii, has been recently isolated from the rumen of cattle 
(Lan et al., 2002) and is a member of the Veillonellaceae family that has been 
previously demonstrated to be reduced in HFD-fed rats (Yin et al., 2013). In our 
experiment, Veillonellaceae did not statistically differ between groups but, as observed 
in the PCA, it was represented in a greater extent in HFS diet-fed rats. On the other 
hand, Bilophila wadsworthia from Desulfovibrionaceae family was increased after the 
HFS treatment in our rats. Bilophila wadsworthia is defined as a sulphate-reducing, bile 
resistant bacteria, difficult to detect in healthy individuals (Devkota et al., 2012) while it 
has been reported to increase under inflammatory conditions (Devkota et al., 2012). 
Moreover, the growth of this bacterium has been related to the suppression of 
symbiotic, commensal microbes, which might allow pathobionts and pathogens to 
establish in the intestine (Devkota et al., 2012). The relative abundance of other 
bacterial species, such as Prevotella micans, Prevotella marshii, Prevotella sp. oral 
taxon 302 and Prevotella sp. B31 FD and especially Prevotella nanceiensis were found 
to be increased after the intervention, even if the relative levels of the Prevotellaceae 
family were found to be reduced. Members of this family are classified as acetate and 
H -producers (Marounek and Dušková, 19992 ) and, contrarily to what we observed in 
rats,  have been found to be enriched in obese human subjects (Zhang et al., 2009). 
Nevertheless, dietary patterns such as high fiber intake have been reported to impact in 
the abundance of this group (De Filippo et al., 2010). Therefore, taking into account 
that Prevotella nanceiensis is able to ferment saccharides such as sucrose, mannose and 
raffinose (Alauzet et al., 2007), the increases detected in this bacterial species and 
related members, could be attributed to dietary macronutrients (carbohydrates) 
modifications. On the other hand, PCA showed that Clostridiaceae family was greatly 
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present in faecal samples from control diet-fed lean rats. However, a significant 
expansion in the levels of Clostridium sp. FCB90-3, Clostridium sp. BNL1100, as well 
as a slight increase in Clostridium algidixylanolyticum and Clostridium sp. C9 members 
within this family was detected at the end of the intervention in our study. In contrast, 
our results revealed that, the HFS diet negatively affected Clostridium species 
belonging to Clostridia cluster XIVa (Clostridium hathewayi, Clostridium aerotolerans, 
Clostridium xylanovorans and [Ruminococcus] obeum), although the reduction was 
statistically significant only for Clostridium fusiformis. Bacterial species from this 
group have been demonstrated to be negatively affected in obesity (Cani and Delzenne, 
2009). Indeed, they are major producers of SCFA (that decreased with the HFS diet), 
especially butyrate, which has been shown to play a role in the protection against 
harmful inflammatory responses (Donohoe et al., 2011). In addition, the decreases 
found in the levels of Clostridium clariflavum, a cellulose-digesting bacteria classified 
within the Clostridium cluster III, denotes the potential influence of the diet or specific 
nutrients on gut microbial community (Shiratori et al., 2009). Other members from the 
Firmicutes phylum, Eubacterium ventriosum and Eubacterium cylindroides, were 
considerably increased after the experimental period in faeces from the HFS-induced 
overweight rats. Interestingly, Eubacterium ventriosum has been positively correlated to 
body mass index (Tims et al., 2013) while Eubacterium cylindroides, is a member of 
the Erysipelotrichiciae family, and probably the major contributor to a high abundance 
in our study. Moreover, this bacterium has been reported to be up regulated in high-fat 
diet induced obesity and in faecal microbiota of obese humans (Ley et al., 2005; 
Turnbaugh et al., 2008). Finally, higher levels of Lactobacillus reuteri at the end of the 
intervention (Lactobacillaceae family) were found in agreement with previous studies 
(Million et al., 2012). 
 
Our data indicate that gut microbial ecology, apart from being modified at highest 
division levels, responds to the diet in a species-dependent manner. Furthermore, it is 
noteworthy that differential response patterns could be given when phylogenetic 
analyses are conducted at deeper levels. Herein, we attempted to characterize the gut 
microbiota modifications resulted from the intake of an obesogenic diet in Wistar rats. It 
should be emphasized that in this experiment, the same group of animals’ was tested at 
different time points of the study (baseline and after the HFS diet treatment). This way, 
the problem of inter-individual variability was overcome as genetic differences within 
animals were avoided, and the identical “inherited“ pattern of microbes was ensured. 
Nevertheless, there are several limitations that should be mentioned. Firstly, we did not 
have a separate group of rats that were fed a standard diet for the same period of time (6 
weeks) that would serve as a control group. Moreover, the sample size used in the study 
(n=5) was small providing a low statistical power after the correction for multiple 
comparison. In this regard, the low power of the study could lead to Type II Error or 
false negatives. Nevertheless, it was enough to detect reported differences, thus it could 
be mentioned that the weakness associated to the small sample size was that we likely 
failed to identify more statistical significances in other comparisons performed. 
Furthermore, we are also concerned that the sample size was small based on the 
demonstrated genetic variance in rats (Levin, 1990) that could have made some animals 
prone to obesity and others resistant to obesity when fed the high-energy diet. Secondly, 
we have only observed the modifications produced by a unique diet, thus the relevance 
of different components from the diet cannot be separately elucidated. Finally, it is 
remarkable that this study has been conducted in rats whereas microbiota analyses from 
most of the cited articles have been performed in mice or in humans. Thus, disparities 
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with other studies could be due to factors such as diet, age, degree of obesity, sample 
size, sample collection and manipulation, techniques and methodology used that could 
profoundly affect gut microbes identification. Still, this study brings light to the fact that 
specific species (Mitsuokella jalaludinii, Eubacterium ventriosum, Prevotella 
nanceiensis, Eubacterium cylindroides and some Clostridium species), detected by a 
high-throughput technique, are affected by an intervention period with a HFS diet in 
Wistar rats, as well as the widely reported Firmicutes, Bacteroidetes, Proteobacteria 
phyla and Erysipelotrichi class. 
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